Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Tecarfarin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 510Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cadrenal Expands Anticoagulation Platform In $40B Market
    Cadrenal Expands Anticoagulation Platform In $40B Market

    12 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-12/cadrenals-anticoagulation-platform-is-expanding-in-a-40-billion-market

    PHARMIWEB
    12 Dec 2025
    Share Share
    Cadrenal's Quiet Expansion Play Is Starting To Get Loud
    Cadrenal's Quiet Expansion Play Is Starting To Get Loud

    12 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-12/cadrenals-quiet-expansion-play-is-starting-to-get-loud

    PHARMIWEB
    12 Dec 2025
    Share Share
    Cadrenal Therapeutics Reports Q3 Financials & Corporate Updates
    Cadrenal Therapeutics Reports Q3 Financials & Corporate Updates

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184629/0/en/Cadrenal-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Cadrenal Plans Tecarfarin Trial for ESKD Patients to Dialysis
    Cadrenal Plans Tecarfarin Trial for ESKD Patients to Dialysis

    05 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250805824561/en/Cadrenal-Therapeutics-Announces-Clinical-Trial-Initiation-Plans-for-Tecarfarin-in-Patients-with-End-Stage-Kidney-Disease-ESKD-Transitioning-to-Dialysis

    BUSINESSWIRE
    05 Aug 2025
    Share Share
    Cadrenal Therapeutics Reports Full Year 2024 Results and Business
    Cadrenal Therapeutics Reports Full Year 2024 Results and Business

    13 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250313043048/en/Cadrenal-Therapeutics-Reports-Full-Year-2024-Results-Business-Highlights-and-Path-Forward-for-Clinical-Advancement-of-Tecarfarin

    BUSINESSWIRE
    13 Mar 2025
    Share Share
    Cadrenal, Abbott Partner For Tecarfarin Study In HeartMate 3™ LVAD
    Cadrenal, Abbott Partner For Tecarfarin Study In HeartMate 3™ LVAD

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304792377/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.